The largest database of trusted experimental protocols

Anti dnmt3a sc 365769

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Anti-DNMT3a (sc-365769) is a primary antibody produced by Santa Cruz Biotechnology. It is designed to detect DNMT3a, a DNA methyltransferase enzyme that is involved in de novo DNA methylation.

Automatically generated - may contain errors

2 protocols using anti dnmt3a sc 365769

1

Colorectal cancer cell line cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colorectal cancer cell lines HCT116 and SW480, and mouse colon carcinoma cell line CT26 were cultured in a complete RPMI 1640 growth medium (Thermo Fisher Scientific, CA, USA) with 10% fetal bovine serum (Invitrogen, CA, USA), 3.5 g/L glucose (Thermo Fisher Scientific, CA, USA), 10 mM HEPES (Thermo Fisher Scientific, CA, USA), and 1.0 mM sodium pyruvate (Thermo Fisher Scientific, CA, USA) at 37 °C in an incubator of 5% CO2 and 95% air.
The following antibodies were used in this study: anti-PD-L1 (ab205921, clone 28-8, Abcam, Cambridge, UK) anti-PD-L1 (#13684, clone E1L3N, Cell Signaling Technology, MA, USA), anti-β-actin (sc-8432, Santa Cruz, CA, USA), anti-DNMT3a (sc-365769, Santa Cruz, CA, USA), anti-DNMT1 (sc-271729, Santa Cruz, CA, USA), anti-p-signal transducer and activator of transcription 1 (p-STAT1, sc-8394, Santa Cruz, CA, USA), anti-STAT1 (sc-464, Santa Cruz, CA, USA), anti-interferon regulatory factor 1 (IRF1, sc-514544, Santa Cruz, CA, USA), and horseradish peroxidase (HRP)-conjugated secondary antibodies (Santa Cruz, CA, USA).
Lentiviruses carrying individual shRNA were obtained from the National Core Facility for Manipulation of Gene Function by RNAi, miRNA, miRNA sponges, and CRISPR/Genomic Research Center, Academia Sinica, Taipei, Taiwan.
+ Open protocol
+ Expand
2

Quantifying Cellular Methyltransferases by Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed using RIPA buffer
(Tris-HCl, pH 7.6, 50 mM, deoxycholic acid sodium salt 0.5%, NaCl
140 mM, NP40 1%, EDTA 5 mM, NaF 100 mM, sodium pyrophosphate 2 mM)
and protease inhibitors. Lysates were separated on an 8% acrylamide
gel and immunoblotted using standard procedures. The following antibodies
were used: anti-DNMT1 (sc-20701; Santa Cruz Biotechnology), anti-DNMT3a
(sc-365769; Santa Cruz Biotechnology), and anti-DNMT3b (sc-10236;
Santa Cruz Biotechnology).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!